Adicet Bio, Inc. also files under TORC; those filings are included. Filings under ACET by Aceto Corp (CIK 0000002034) from Jan 3, 2006 to Feb 26, 2019 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Klickstein Lloyd | Chief Medical Officer, Director | Grant(A) | 18K | — | $0 |
| Jun 21, 2026 | Dubin Steve | Director | Grant(A) | 4K | — | $0 |
| Jun 21, 2026 | Klickstein Lloyd | Director | Grant(A) | 4K | — | $0 |
| Jun 21, 2026 | Sinclair Andrew | Director | Grant(A) | 4K | — | $0 |
| Jun 21, 2026 | Peng Katie | Director | Grant(A) | 4K | — | $0 |
| Jun 21, 2026 | Chodakewitz Jeffrey | Director | Grant(A) | 4K | — | $0 |
| Jun 21, 2026 | Grissinger Michael | Director | Grant(A) | 4K | — | $0 |
| Jun 19, 2026 | Aftab Blake | Chief Scientific Officer | Grant(A) | 55K | — | $0 |
| Jun 19, 2026 | Schor Chen | President & CEO, Director | Grant(A) | 55K | — | $0 |
| Apr 27, 2026 | Ra Capital Management, L.P. | 10% Owner | Other(J) | 250K | — | — |
| Apr 27, 2026 | Ra Capital Management, L.P. | 10% Owner | Other(J) | 250K | — | — |
| Apr 8, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 33K | $6.29 | $205K |
| Apr 8, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 40K | $6.52 | $264K |
| Apr 7, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 2K | $6.38 | $15K |
| Apr 7, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 29K | $6.53 | $191K |
| Mar 25, 2026 | Healey Don | Chief Technology Officer | Grant(A) | 43K | — | $0 |
| Mar 25, 2026 | Aftab Blake | Chief Scientific Officer | Grant(A) | 73K | — | $0 |
| Mar 25, 2026 | Harvey Brian Nicholas | Chief Financial Officer | Grant(A) | 43K | — | $0 |
| Mar 25, 2026 | Maltzman Julia D. | Chief Medical Officer | Grant(A) | 73K | — | $0 |
| Mar 25, 2026 | Schor Chen | President & CEO, Director | Grant(A) | 469K | — | $0 |
| Feb 20, 2026 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 75K | $7.27 | $543K |
| Feb 19, 2026 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 74K | $7.21 | $535K |
| Feb 18, 2026 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 75K | $7.04 | $525K |
| Jan 24, 2026 | Healey Don | Chief Technology Officer | Tax withholding(F) | 535 | $8.44 | $5K |
| Jan 24, 2026 | Schor Chen | President & CEO, Director | Tax withholding(F) | 2K | $8.44 | $15K |
| Jan 24, 2026 | Harvey Brian Nicholas | Chief Financial Officer | Tax withholding(F) | 546 | $8.44 | $5K |
| Jan 24, 2026 | Aftab Blake | Chief Scientific Officer | Tax withholding(F) | 535 | $8.44 | $5K |
| Oct 8, 2025 | Orbimed Advisors LLC | 10% Owner | Buy(P) | 3.5M | $1.00 | $3.5M |
| Oct 8, 2025 | Orbimed Advisors LLC | 10% Owner | Buy(P) | 1.5M | $1.00 | $1.5M |
| Jun 11, 2025 | Peng Katie | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2025 | Sinclair Andrew | Director | Grant(A) | 26K | — | $0 |
| Jun 11, 2025 | Sinclair Andrew | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2025 | Klickstein Lloyd | Director | Grant(A) | 26K | — | $0 |
| Jun 11, 2025 | Chodakewitz Jeffrey | Director | Grant(A) | 26K | — | $0 |
| Jun 11, 2025 | Peng Katie | Director | Grant(A) | 26K | — | $0 |
| Jun 11, 2025 | Klickstein Lloyd | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2025 | Chodakewitz Jeffrey | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2025 | Dubin Steve | Director | Grant(A) | 26K | — | $0 |
| Jun 11, 2025 | Dubin Steve | Director | Grant(A) | 6K | — | $0 |
| Apr 17, 2025 | Grissinger Michael | Director | Grant(A) | 70K | — | $0 |
| Jan 31, 2025 | Harvey Brian Nicholas | Chief Financial Officer | Grant(A) | 324K | — | $0 |
| Jan 31, 2025 | Aftab Blake | Chief Scientific Officer | Grant(A) | 275K | — | $0 |
| Jan 31, 2025 | Healey Don | Chief Technology Officer | Grant(A) | 275K | — | $0 |
| Jan 31, 2025 | Maltzman Julia D. | Chief Medical Officer | Grant(A) | 750K | — | $0 |
| Jan 31, 2025 | Schor Chen | President & CEO, Director | Grant(A) | 764K | — | $0 |
| Jan 24, 2025 | Schor Chen | President & CEO, Director | Tax withholding(F) | 28K | $0.92 | $26K |
| Jan 24, 2025 | Aftab Blake | Chief Scientific Officer | Tax withholding(F) | 6K | $0.92 | $6K |
| Jan 24, 2025 | Healey Don | Chief Technology Officer | Tax withholding(F) | 9K | $0.92 | $8K |
| Jan 24, 2025 | Harvey Brian Nicholas | Chief Financial Officer | Tax withholding(F) | 9K | $0.92 | $8K |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Grant(A) | 30K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Disposed to issuer(D) | 26K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Grant(A) | 26K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Disposed to issuer(D) | 30K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Chodakewitz Jeffrey | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Disposed to issuer(D) | 26K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Grant(A) | 26K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Disposed to issuer(D) | 30K | — | $0 |
| Aug 21, 2024 | Peng Katie | Director | Disposed to issuer(D) | 70K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Grant(A) | 30K | — | $0 |
| Aug 21, 2024 | Dubin Steve | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Kauffman Michael | Director | Disposed to issuer(D) | 26K | — | $0 |
| Aug 21, 2024 | Kauffman Michael | Director | Disposed to issuer(D) | 37K | — | $0 |
| Aug 21, 2024 | Kauffman Michael | Director | Grant(A) | 26K | — | $0 |
| Aug 21, 2024 | Kauffman Michael | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Kauffman Michael | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Disposed to issuer(D) | 26K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Disposed to issuer(D) | 8K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Kauffman Michael | Director | Grant(A) | 37K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Grant(A) | 8K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Disposed to issuer(D) | 26K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Grant(A) | 26K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Grant(A) | 29K | — | $0 |
| Aug 21, 2024 | Sinclair Andrew | Director | Disposed to issuer(D) | 29K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Grant(A) | 26K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Grant(A) | 26K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Disposed to issuer(D) | 26K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Disposed to issuer(D) | 30K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Disposed to issuer(D) | 19K | — | $0 |
| Aug 21, 2024 | Gordon Carl L | Director, 10% Owner | Grant(A) | 19K | — | $0 |
| Aug 21, 2024 | Peng Katie | Director | Grant(A) | 70K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Grant(A) | 30K | — | $0 |
| Aug 21, 2024 | Jakobovits Aya | Director | Disposed to issuer(D) | 30K | — | $0 |
| Aug 19, 2024 | Klickstein Lloyd | Director | Grant(A) | 70K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Adicet Bio, Inc., SEC CIK 0001720580. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ACET and shows every filing by that issuer (also filed as TORC). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for ACET